← Back to Search

Cognitive Behavioral Therapy

Internet Cognitive Behavioral Therapy for Depression

N/A
Waitlist Available
Led By Xiaoling Xiang, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
have at least mild depressive symptoms, based on PHQ-9 >=5
≥50 years
Must not have
Have severe vision impairment that can not be corrected and with no in-home help to assist them with using a mobile device
They do not speak English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline phq-9 at 10 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests an online therapy program called Empower@Home for older adults with high levels of depression. The program includes online sessions and coaching calls to help participants change negative thoughts and behaviors. It aims to make therapy more accessible for homebound seniors.

Who is the study for?
This trial is for Michigan residents over 50 with mild depression, as indicated by a PHQ-9 score of at least 5. It's not suitable for those with active suicidal thoughts, terminal illness, severe vision impairment without help, probable cognitive impairment, non-English speakers, or recent substance abuse issues.
What is being tested?
The study tests Empower@Home—an internet-based cognitive behavioral therapy program designed to reduce depressive symptoms in older adults. The intervention lasts about 10 weeks and aims to demonstrate improved mood post-treatment.
What are the potential side effects?
Since this is a psychological therapy program delivered online, there are no direct medical side effects like you'd expect from medication; however, participants may experience emotional discomfort addressing mental health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I experience mild or more severe depression symptoms.
Select...
I am 50 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have severe vision problems and no one to help me use a mobile device.
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline phq-9 at 10 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline phq-9 at 10 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Patient Health Questionnaire-9 (PHQ-9)
Modified Treatment Evaluation Inventory
Secondary study objectives
Change in Duke Social Support Index (DSSI)-10
Change in Generalized Anxiety Disorder Assessment-7 (GAD-7)
Change in PROMISE-SI

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Internet-based programExperimental Treatment1 Intervention
Participants will be provided with access to a 9-session online program and will receive supportive remote assistance throughout regarding technical and programmatic issues.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Empower@Home
2022
N/A
~320

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Cognitive Behavioral Therapy (CBT), including its internet-based variant like Empower@Home, works by helping patients identify and change negative thought patterns and behaviors that contribute to their depression. This therapeutic approach aims to improve emotional regulation and develop personal coping strategies. Pharmacotherapy, often involving antidepressants, works by altering brain chemistry to improve mood and emotional state. Understanding these mechanisms is crucial for patients as it helps them make informed decisions about their treatment options, set realistic expectations, and actively engage in their recovery process.
The effectiveness of psychosocial modalities in the treatment of alcohol problems in adults: a review of the evidence.Delineating mechanisms of change in child and adolescent therapy: methodological issues and research recommendations.Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,863 Previous Clinical Trials
6,441,341 Total Patients Enrolled
72 Trials studying Depression
57,805 Patients Enrolled for Depression
Xiaoling Xiang, PhDPrincipal InvestigatorUniversity of Michigan
3 Previous Clinical Trials
390 Total Patients Enrolled
3 Trials studying Depression
390 Patients Enrolled for Depression

Media Library

Empower@Home (Cognitive Behavioral Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05384704 — N/A
Depression Research Study Groups: Internet-based program
Depression Clinical Trial 2023: Empower@Home Highlights & Side Effects. Trial Name: NCT05384704 — N/A
Empower@Home (Cognitive Behavioral Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05384704 — N/A
Depression Patient Testimony for trial: Trial Name: NCT05384704 — N/A
~67 spots leftby Dec 2025